Markus Lucerna

Specificity, diversity, and convergence in VEGF and TNF‐α signaling events leading to tissue factor up regulation via EGR‐1 in endothelial cells

Diana Mechtcheriakova, Gernot Schabbauer, Markus Lucerna et al. · The FASEB Journal · 2001 · 183 citations

Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation

Renate B. Schnabel, Ladislav Pecen, Francisco Ojeda et al. · Heart · 2017 · 181 citations · Full text

Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub‐Analysis From the PREFER in AF ( <i>PRE</i> vention o <i>F</i> Thromboembolic Events– <i>E</i> uropean <i>R</i> egistry in <i>A</i> trial <i>F</i> ibrillation)

Giuseppe Patti, Markus Lucerna, Ladislav Pecen et al. · Journal of the American Heart Association · 2017 · 167 citations · Full text

An Inhibitory Role of the Phosphatidylinositol 3-Kinase-signaling Pathway in Vascular Endothelial Growth Factor-induced Tissue Factor Expression

Sabine Blum, Katja Issbrüker, Antje Willuweit et al. · Journal of Biological Chemistry · 2001 · 111 citations · Full text

Endothelial Cells, Immunology, Cellular Physiology +18

NAB2, a Corepressor of EGR-1, Inhibits Vascular Endothelial Growth Factor-mediated Gene Induction and Angiogenic Responses of Endothelial Cells

Markus Lucerna, Diana Mechtcheriakova, Alexandra Kadl et al. · Journal of Biological Chemistry · 2003 · 95 citations · Full text